LEGACY HEALTH SYSTEM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

Not Applicable

Terminated

Conditions: Covid19

Interventions: Device: Hyperbaric Oxygen Therapy (HBOT)

First Posted Date: 2020-11-06

Last Posted Date: 2023-03-09

Lead Sponsor: Legacy Health System

Target Recruit Count: 27

Registration Number: NCT04619719

Locations: 🇺🇸
Legacy Emanuel Medical Center, Portland, Oregon, United States
🇺🇸
Bozeman Health, Bozeman, Montana, United States
🇺🇸
NYU Winthrop Hospital, Mineola, New York, United States

Supracondylar Pinning Antibiotic Stewardship (SPAS) Trial

Not Applicable

Conditions: Infection
Supracondylar Humerus Fracture

Interventions: Drug: normal saline
Drug: Cefazolin

First Posted Date: 2020-02-28

Last Posted Date: 2022-04-12

Lead Sponsor: Legacy Health System

Target Recruit Count: 1200

Registration Number: NCT04288206

Locations: 🇺🇸
Legacy Emanuel Medical Center, Portland, Oregon, United States

Effects of HBO on Glucose in Patients With DM

Not Applicable

Suspended

Conditions: Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions: Device: Hyperbaric Oxygen

First Posted Date: 2020-02-10

Last Posted Date: 2024-05-16

Lead Sponsor: Legacy Health System

Target Recruit Count: 24

Registration Number: NCT04261738

Locations: 🇺🇸
Legacy Emanuel Medical Center, Portland, Oregon, United States

Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation

Phase 4

Conditions: Extracorporeal Membrane Oxygenation Complication
Anticoagulants

Interventions: Drug: Bivalirudin
Drug: Unfractionated heparin

First Posted Date: 2019-05-28

Last Posted Date: 2019-05-28

Lead Sponsor: Legacy Health System

Target Recruit Count: 34

Registration Number: NCT03965208

Locations: 🇺🇸
Legacy Health System, Portland, Oregon, United States

Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Procedure: Hyperbaric Oxygen Therapy
Drug: Trental Pill
Dietary Supplement: Vitamin E

First Posted Date: 2019-04-16

Last Posted Date: 2023-10-04

Lead Sponsor: Legacy Health System

Target Recruit Count: 1

Registration Number: NCT03916068

Locations: 🇺🇸
Legacy Emanuel Medical Center, Portland, Oregon, United States

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

Not Applicable

Conditions: Climacteric; Menorrhagia, Menopausal
Menopause

Interventions: Dietary Supplement: 100 mg PYC and then placebo
Dietary Supplement: Placebo and then 100 mg PYC
Dietary Supplement: Placebo and then 50 mg PYC
Dietary Supplement: 50 mg PYC and then placebo

First Posted Date: 2018-10-12

Last Posted Date: 2018-10-12

Lead Sponsor: Legacy Health System

Target Recruit Count: 40

Registration Number: NCT03704454

Locations: 🇺🇸
Legacy Meridian Park Medical Center, Tualatin, Oregon, United States
🇺🇸
Legacy Good Samaritan Medical Center, Portland, Oregon, United States
🇺🇸
Legacy Mt. Hood Medical Center, Gresham, Oregon, United States

Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer

Not Applicable

Completed

Conditions: Rectal Cancer
Colon Cancer

Interventions: Dietary Supplement: cholecalciferol

First Posted Date: 2015-11-13

Last Posted Date: 2020-10-01

Lead Sponsor: Legacy Health System

Target Recruit Count: 70

Registration Number: NCT02603757

Locations: 🇺🇸
Legacy Meridian Park Medical Center, Tualatin, Oregon, United States
🇺🇸
Legacy Mount Hood Medical Center, Gresham, Oregon, United States
🇺🇸
Legacy Good Samaritan Medical Center, Portland, Oregon, United States

Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver

Not Applicable

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Glucagon

First Posted Date: 2013-11-18

Last Posted Date: 2015-05-04

Lead Sponsor: Legacy Health System

Target Recruit Count: 12

Registration Number: NCT01986231

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Artificial Pancreas Control System in an Outpatient Setting

Phase 2

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Device: Artificial Pancreas Control Software

First Posted Date: 2013-06-07

Last Posted Date: 2015-05-15

Lead Sponsor: Legacy Health System

Target Recruit Count: 20

Registration Number: NCT01871870

Locations: 🇺🇸
Legacy Research Institute, Portland, Oregon, United States

Preoperative Pain Control in Gastric Bypass Surgery Patients

Phase 4

Completed

Conditions: Post-operative Pain

Interventions: Drug: Placebo (for Pregabalin)
Drug: Pregabalin

First Posted Date: 2013-02-28

Last Posted Date: 2022-07-14

Lead Sponsor: Legacy Health System

Target Recruit Count: 61

Registration Number: NCT01801189

Locations: 🇺🇸
Legacy Good Samaritan Medical Center, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy